FDA Inspection
Combino Pharm (Malta) LtdCombino Pharm (Malta) Ltd – FDA Inspection, Mar 10, 2022
Record Details
This FDA Inspection record concerns Combino Pharm (Malta) Ltd, with an inspection on March 10, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Combino Pharm (Malta) Ltd
- Inspection Date
- March 10, 2022
- Product Type
- Drugs
View Company Profile
ID · a0c0e56c-2e3d-4abf-8bc7-47f4da5127bd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1268103
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Combino Pharm (Malta) Ltd
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 17, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 3, 2017 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
Other documents for Combino Pharm (Malta) Ltd
- FDA Inspection 1120331 - 2019-07-17
- FDA Inspection 1006240 - 2017-03-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.